Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-10-16
1997-10-14
Kmode, Marian C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 17, 514 19, 514402, 530330, 530332, 5483701, A61K 3800, A61K 31415, C07K 500, C07D23104
Patent
active
056772831
ABSTRACT:
Compounds which Inhibit interleukin-1.beta. protease activity, pharmaceutical compositions containing the compounds and methods using the compounds are provided. The compounds have the formula ##STR1## wherein n is 0-2; each AA is Independently L-valine or L-alanine;
R.sub.1 is selected from the group consisting of N-2-(quinuclidinyl)carbonyl, N-(3-pyridyl)methoxy carbonyl, N-(2-pyddyl)methoxy carbonyl, N-methyl-N-benzyl carbonyl, carbonyl; and
R.sub.8, R.sub.9 and R.sub.10 are as defined below.
REFERENCES:
patent: 5055451 (1991-10-01), Krantz et al.
patent: 5434248 (1995-07-01), Chapman et al.
Awad Mohamed M. A.
Chaturvedula Prasad V.
Dolle Roland E.
Hoyer Denton W.
Prouty Catherine
Balogh Imre
Davis William J.
Kmode Marian C.
Prickril Benet
Sanofi
LandOfFree
.alpha.-heteroaryloxymethyl ketones as interleukin - 1 .beta. co does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .alpha.-heteroaryloxymethyl ketones as interleukin - 1 .beta. co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .alpha.-heteroaryloxymethyl ketones as interleukin - 1 .beta. co will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1555342